-
Nov 7, 2024 | 
onlinelibrary.wiley.com | Elizabeth Webb |Anne Holland |Anne B. Chang |Peter Middleton |Rachel Thomson |Conroy Wong | +4 more
CONFLICT OF INTEREST STATEMENT P.G.M is principal investigator on Insmed, AbbVie, Sanofi bronchiectasis trials, LCM. R.M.T is the principal investigator for Insmed, ZAMBON trials; Ad boards Beyond Air, AN2 trials. Nil other conflicts of interest were declared. Part of this study has been presented at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting in 2022. Supporting Information Filename Description ppul27370-sup-0001-supmat.docx23.6 KB Supporting information.
-
Oct 9, 2024 | 
err.ersjournals.com | Angela Burge |Anna Spathis |Natasha Smallwood |Anne Holland
IntroductionPeople with serious respiratory illness experience a high symptom burden, including fatigue, which is highly prevalent and has a profound impact on daily life participation and health-related quality of life (HRQoL) [1–5]. Fatigue is reported by up to 95% of people with COPD or interstitial lung disease (ILD) and 60% of people with asthma or pulmonary hypertension [1–4].
-
Sep 29, 2024 | 
insightplus.mja.com.au | Anne Holland
The proposed sale of Vectura by Philip Morris International is a significant moment in the fight against Big Tobacco’s influence on health care. The Thoracic Society of Australia and New Zealand explores the implications of the sale and calls for continued vigilance to keep tobacco and vaping companies out of the pharmaceutical sector.
-
Aug 18, 2024 | 
mja.com.au | Anne Holland |Simone Dal Corso |Simone Dal
Med J Aust 2024; 221 (4): 226-226. || doi: 10.5694/mja2.52377 Published online: 19 August 2024 In reply: We thank Millar1 for taking the time to respond to our article,2 which details an evaluation of the Alfred Health post‐COVID‐19 clinical service established in June 2020.
-
Aug 8, 2024 | 
erj.ersjournals.com | Melissa Chong |Anne Holland |Angela Burge
FootnotesAuthor contributions: Conceptualisation and design: N.S. Cox. Data acquisition: M. Chong, A.E. Holland, A.T. Burge, J. Perrryman and N.S. Cox. Data analysis: M. Chong and N.S. Cox. Drafting manuscript: M. Chong and N.S. Cox. Critical review of manuscript: M. Chong, A.E. Holland, A.T. Burge, J. Perrryman and N.S. Cox. Conflict of interest: The authors have no potential conflicts of interest to disclose.
-
Jul 26, 2024 | 
erj.ersjournals.com | Melissa Chong |Anne Holland |Angela Burge
FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of Interest: All authors have nothing to disclose. Received March 5, 2024.
-
Jul 24, 2024 | 
medrxiv.org | Anthony May |Anne Holland |Jennifer Alison |Kelcie Herrmann
The authors have declared no competing interest. No funding was received for this research. NSC and AEH receive research fellowship support from the National Health and Medical Research Council (NHMRC) (GNT2016286 and GNT1197007, respectively). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
-
Jun 28, 2024 | 
erj.ersjournals.com | Anne Holland |Anna Spathis |Claudia Bausewein |Angela Burge
IntroductionChronic lung diseases, such as COPD and interstitial lung disease (ILD), are among the leading causes of disability and premature death worldwide [1]. Respiratory symptoms, predominantly breathlessness and cough, are widely reported by people with serious respiratory illness and adversely impact health-related quality of life (HRQoL) [2, 3]. Breathlessness may be insufficiently recognised [4] and under-treated [5].
-
May 8, 2024 | 
erj.ersjournals.com | Anne Holland |Anna Spathis |Claudia Bausewein |Angela Burge
FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
-
Feb 4, 2024 | 
mja.com.au | Dal Corso |Anne Holland |Daniel Fineberg |Tunya Marceau
Med J Aust 2024; 220 (2): 91-96.
